The following information is disclosed in accordance with Rule 26 of the AIM Rules (May 2008):
Please click on the link below for a description of the business.
Please click on the link below for the names of the directors and brief biographical details of each.
Please click on the links below for a description of Directors' responsibilities.
Please click on the link below for information on the Audit, Nomination and Remuneration Committees together with the membersip of these committees.
Genosis was incorporated in England and Wales on 1 March 2005 which is also its main country of operation.
Please click on the link below for the Memorandum and Articles of Association.
Memorandum and Articles of Association
The company is not listed on any other exchanges.
In conformity with the Transparency Directive, the Company's issued capital consists of 33,339,071 ordinary shares of 10 pence each (“Ordinary Shares”), all with voting rights. No shares were held in treasury. The total number of current voting rights in the Company is therefore 33,339,071.
The above figure (33,339,071 Ordinary Shares) may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FSA's Disclosure and Transparency Rules.
There are no restrictions on the transfer of securities.
Please click on the link below for access to the Company's annual and interim reports.
Please click on the link below to access notifications made by the Company in the last 12 months.
Please click on the link below to access the Company's Admission Document dated 2nd December 2005 and the Subscription of new Ordinary Shares Circular dated 18th May 2007.
Please click on the link below for details of the Company's Nominated Adviser and other key advisers.